ARA160 Activators
ARA160 activators encompass a diverse array of chemical compounds known to enhance the functional activity of the protein ARA160 through various signaling mechanisms. Compounds such as Forskolin, Isoproterenol, and PGE1 (Alprostadil) directly engage with the cAMP signaling cascade, a pivotal pathway in which ARA160 is functionally involved. Forskolin, acting as an adenylyl cyclase stimulator, leads to an uplift in the intracellular levels of cAMP, a critical second messenger that ARA160 relies on for its activation. Similarly, Isoproterenol, through its action on beta-adrenergic receptors, and PGE1, via its G-protein coupled receptor interaction, both result in elevated cAMP levels, thereby promoting ARA160's activity by fortifying the pathways it is integrated with.
Moreover, a range of phosphodiesterase inhibitors such as IBMX, Rolipram, Sildenafil, Cilostazol, Anagrelide, and Vinpocetine, indirectly contribute to the augmentation of ARA160's function by sustaining thelevels of cAMP or cGMP within the cell. IBMX, a non-selective inhibitor, and Rolipram, a PDE4-specific inhibitor, prevent the breakdown of cAMP, thus indirectly enhancing the signaling pathways that ARA160 is implicated in. Sildenafil and Zaprinast, both targeting PDE5, and Cilostazol and Anagrelide, which inhibit PDE3, maintain elevated cAMP levels, reinforcing the signaling mechanisms that underpin ARA160's role. Further diversifying the chemical landscape of ARA160 activators, L-Arginine and Dopamine operate through the production of nitric oxide and dopamine receptor signaling respectively, both of which can culminate in increased cAMP levels, a common denominator in the activation of ARA160.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylyl cyclase, increasing intracellular cAMP levels. ARA160, being a protein that responds to cAMP levels, is functionally activated as cAMP serves as a second messenger in various signal transduction pathways that ARA160 is involved in. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol, a synthetic catecholamine, activates beta-adrenergic receptors leading to the activation of Gs proteins and subsequent increase in cAMP production. Elevated cAMP activates proteins in signaling pathways related to ARA160 function. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX inhibits phosphodiesterases, which degrade cAMP. By preventing cAMP breakdown, IBMX indirectly enhances the signaling pathways that regulate ARA160 function due to increased cAMP availability. | ||||||
L-Arginine | 74-79-3 | sc-391657B sc-391657 sc-391657A sc-391657C sc-391657D | 5 g 25 g 100 g 500 g 1 kg | $20.00 $31.00 $61.00 $219.00 $352.00 | 2 | |
L-Arginine serves as a substrate for nitric oxide synthase, leading to the production of nitric oxide (NO). NO activates guanylate cyclase, increasing cGMP levels, which can cross-activate pathways involving cAMP, thus potentially enhancing ARA160 activity. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast is a selective inhibitor of phosphodiesterase type 5 (PDE5), which specifically degrades cGMP. By stabilizing cGMP levels, zaprinast may indirectly influence cAMP-related pathways and thereby enhance ARA160 activity. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram selectively inhibits phosphodiesterase type 4 (PDE4), leading to an increase in cAMP levels. This accumulation of cAMP can enhance the activation of signaling pathways that ARA160 participates in. | ||||||
Cilostazol | 73963-72-1 | sc-201182 sc-201182A | 10 mg 50 mg | $109.00 $322.00 | 3 | |
Cilostazol inhibits PDE3, which increases cAMP levels by preventing its degradation. The elevated cAMP can enhance ARA160 activation by strengthening the signaling pathways it is involved in. | ||||||
PGE1 (Prostaglandin E1) | 745-65-3 | sc-201223 sc-201223A | 1 mg 10 mg | $31.00 $145.00 | 16 | |
PGE1 activates its cognate G-protein coupled receptors, leading to an increase in cAMP production. This mechanism can enhance the signaling pathways that ARA160 is part of, thus increasing its functional activity. | ||||||
Dopamine | 51-61-6 | sc-507336 | 1 g | $290.00 | ||
Dopamine binds to its G-protein coupled receptors, particularly D1-like receptors which can increase cAMP levels. This elevation of cAMP may enhance the signaling pathways that involve ARA160, thus increasing its functional activity. | ||||||
Anagrelide hydrochloride | 58579-51-4 | sc-203513 sc-203513A | 10 mg 50 mg | $103.00 $587.00 | 1 | |
Anagrelide inhibits PDE3, leading to increased cAMP levels and enhanced signaling pathways associated with ARA160, thus indirectly increasing its functional activity. | ||||||